ConductScience.org, home

Paper6178564

The biology and pathogenesis of coronaviruses.

Wege H and 2 others. Curr Top Microbiol Immunol, 1982. Cited by 356 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The biology and pathogenesis of coronaviruses. Papers, record 6178564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6178564

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The biology and pathogenesis of coronaviruses.
PubMed
Journal
Curr Top Microbiol Immunol
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
356
iCite
Relative citation ratio, by iCite
8.7
iCite
Revised in PubMed
2019-08-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wege HH
2Siddell SS
3ter Meulen VV

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CoronaviridaeMajor topic
Animals
Antigens, Viral
Bronchitis
Cats
Cattle
Cross Reactions
Dog Diseases
Dogs
Enteritis
Epitopes
Hepatitis
Humans
Mice
Nucleic Acid Hybridization
Peritonitis
Poultry Diseases
RNA, Viral
Rodent Diseases
Turkeys

Source PubMed

Cited by213

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 356 citations.

PMIDTitleJournalYearIn PapersSource
38,247,540Anastrozole Protects against Human Coronavirus Infection by Ameliorating the Reactive Oxygen Species-Mediated Inflammatory Response.Antioxidants (Basel)2024https://conductscience.org/library/papers/38247540PubMed
37,243,102Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).Vaccines (Basel)2023https://conductscience.org/library/papers/37243102PubMed
37,197,656Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.Front Immunol2023https://conductscience.org/library/papers/37197656PubMed
37,153,539Critical role of TLR activation in viral replication, persistence, and pathogenicity of Theiler's virus.Front Immunol2023https://conductscience.org/library/papers/37153539PubMed
36,851,792Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19.Viruses2023https://conductscience.org/library/papers/36851792PubMed
36,754,290Possible spread of SARS-CoV-2 in domestic and wild animals and body temperature role.Virus Res2023https://conductscience.org/library/papers/36754290PubMed
35,336,888Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP).Viruses2022https://conductscience.org/library/papers/35336888PubMed
35,215,991Reduction of Cell Fusion by Deletion in the Hypervariable Region of the Spike Protein of Mouse Hepatitis Virus.Viruses2022https://conductscience.org/library/papers/35215991PubMed
34,267,652Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection.Front Pharmacol2021https://conductscience.org/library/papers/34267652PubMed
34,188,334Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature.Scientometrics2021https://conductscience.org/library/papers/34188334PubMed
34,067,536Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.Int J Mol Sci2021https://conductscience.org/library/papers/34067536PubMed
33,582,855Viral mouse models used to study multiple sclerosis: past and present.Arch Virol2021https://conductscience.org/library/papers/33582855PubMed
33,331,810Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?J Gen Virol2021https://conductscience.org/library/papers/33331810PubMed
33,316,002Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection.Med J Islam Repub Iran2020https://conductscience.org/library/papers/33316002PubMed
33,282,073Guillain-Barré syndrome associated with COVID-19 infection.Pan Afr Med J2020https://conductscience.org/library/papers/33282073PubMed
32,720,031The kidney, COVID-19, and the chemokine network: an intriguing trio.Int Urol Nephrol2021https://conductscience.org/library/papers/32720031PubMed
32,580,969Coronavirus Disease 2019-COVID-19.Clin Microbiol Rev2020https://conductscience.org/library/papers/32580969PubMed
32,375,268Coronavirus Pandemic-Therapy and Vaccines.Biomedicines2020https://conductscience.org/library/papers/32375268PubMed
32,313,807Guillain-Barré Syndrome associated with SARS-CoV-2 infection.IDCases2020https://conductscience.org/library/papers/32313807PubMed
32,313,392Equine coronavirus: An emerging enteric virus of adult horses.Equine Vet Educ2016https://conductscience.org/library/papers/32313392PubMed

See all 213 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6178564

GET https://conductscience.org/api/papers/v1/6178564/cited_by?page=2